Prebiotics vs. Probiotics: Which Supplements Are Right for You?
Prebiotics feed the beneficial bacteria already in your gut, while probiotics introduce live ones. Learn the key differences, evidence, and when each supplement makes sense.
Prebiotics feed the beneficial bacteria already in your gut, while probiotics introduce live ones. Learn the key differences, evidence, and when each supplement makes sense.
Match supplements to your diet, bloodwork, and life stage, then verify quality and interactions. A practical, evidence-based 7-step framework.
2026 real-world study: 84.4% of cancer patients taking ivermectin and mebendazole reported clinical benefit at 6 months, with nearly half seeing tumor reduction.
Evidence-based look at protein supplements: proven benefits for muscle, weight, and aging, plus heavy metal, kidney, and digestive risks you should know before buying.
Omega-3s reduce triglycerides 20-50% at 2-4 g/day and cut cardiovascular events 25% in high-risk patients (REDUCE-IT), but atrial fibrillation risk tempers enthusiasm.
More than half of US adults take multivitamins, but research shows benefits depend on diet, age, and health status. Here’s who actually benefits and who doesn’t.
Hydrogen water and red light therapy have growing research behind them for athletic recovery. Here’s what the science shows and products worth considering.
Evidence-backed supplements for athletes: creatine, protein, caffeine, beta-alanine, nitrates, omega-3, and vitamin D, with dosing and what to skip.
Evidence-based natural supplements for energy and fatigue: iron, magnesium, B vitamins, vitamin D, ashwagandha, rhodiola, CoQ10, creatine, and NAD+ precursors.
Research-backed supplements and dietary patterns for mental health, including omega-3s, magnesium, vitamin D, B vitamins, zinc, probiotics, and ashwagandha.
A 2025 market worth over $200 billion sells concentrated greens, berries, and algae in capsules, but only a few compounds like curcumin and berberine clear the evidence bar.
Preprint report on 197 cancer patients prescribed compounded ivermectin and mebendazole shows 84.4% clinical benefit ratio at 6 months, with key limitations noted.
Methylene blue, an FDA-approved drug for methemoglobinemia, is being studied in preclinical cancer research for its redox-cycling, ROS, and PDT mechanisms.
Rates of 14 cancer types are rising in adults under 50, with the sharpest jumps in the 20-29 age group. Researchers blame overlapping lifestyle and environmental factors.
Mayo Clinic’s REDMOD AI flags pancreatic cancer on routine CT scans up to 3 years before diagnosis, identifying 73% of cases vs. 39% for specialists alone.